New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 12, 2014
10:31 EDTCHTP, NSR, HZNP, GMCR, OLEDOptions with decreasing implied volatility: CHTP NSR HZNP GMCR OLED
News For CHTP;NSR;HZNP;GMCR;OLED From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 31, 2014
05:54 EDTGMCRStocks with implied volatility above IV index mean; GRPN GMCR
Subscribe for More Information
October 30, 2014
16:17 EDTNSRNeuStar raises FY14 adjusted EPS view to $4.08-$4.25 from $3.88-$4.05
Subscribe for More Information
16:16 EDTNSRNeuStar raises FY14 outlook
16:15 EDTNSRNeuStar reports Q3 adjusted EPS $1.37, consensus $1.04
Reports Q3 revenue $243.9M, consensus $243.24M.
06:02 EDTGMCRStocks with implied volatility above IV index mean; GME GMCR
Subscribe for More Information
October 29, 2014
10:17 EDTGMCRGreen Mountain Coffee calls active
Subscribe for More Information
October 23, 2014
08:12 EDTGMCRKeurig Green Mountain now exclusive manufacturer of Meijer Brand-K-Cup
Keurig Green Mountain announced that it is now the exclusive manufacturer of Meijer Brand K-Cup packs for the Keurig hot brewing system. Financial terms of the agreement were not disclosed. The new Meijer Brand K-Cup packs are now available exclusively at Meijer stores.
07:42 EDTHZNPPOZEN receives three patents from USPTO
POZEN (POZN) announced that it has received three patents from the United States Patent and Trademark Office, entitled “Pharmaceutical Compositions for the Coordinated Delivery of NSAIDs” that cover the U.S. approved product VIMOVO. All three patents are expected to expire in 2022. Horizon Pharma (HZNP), which holds the U.S. NDA for VIMOVO, and POZEN plan to list U.S. patents 8,858,996 and 8,852,636 in the FDA's Approved Drug Products with Therapeutic Equivalence Evaluations, or Orange Book.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use